Olmesartan medoxomil/amlodipine/hydrochlorothiazide
Olmesartan medoxomil/amlodipine/hydrochlorothiazide was ranked 887th of 1,794 medicines by items in March 2026, with 1,053 items, down 1.5% on a year earlier.
1,053items
Dispensed in March 2026
NHSBSA Prescription Cost Analysis
£18,865
Net ingredient cost · March 2026
NHSBSA PCA
12,957items
Dispensed in the last 12 months
NHSBSA PCA
Figure 1. Olmesartan medoxomil/amlodipine/hydrochlorothiazide: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to March 2026
Embed this chart
Top presentations, March 2026
The individual products dispensed under Olmesartan medoxomil/amlodipine/hydrochlorothiazide, by items this month.
| Presentation | Items | Net ingredient cost |
|---|---|---|
| Sevikar HCT 40mg/10mg/25mg tablets | 514 | £7,853 |
| Sevikar HCT 20mg/5mg/12.5mg tablets | 209 | £4,403 |
| Sevikar HCT 40mg/10mg/12.5mg tablets | 172 | £3,448 |
| Sevikar HCT 40mg/5mg/25mg tablets | 99 | £1,971 |
| Sevikar HCT 40mg/5mg/12.5mg tablets | 59 | £1,191 |
Compare Olmesartan medoxomil/amlodipine/hydrochlorothiazide with
Other medicines in the same BNF section, by prescribing volume.
- Olmesartan medoxomil/amlodipine/hydrochlorothiazide vs Ramipril
- Olmesartan medoxomil/amlodipine/hydrochlorothiazide vs Losartan potassium
- Olmesartan medoxomil/amlodipine/hydrochlorothiazide vs Candesartan cilexetil
- Olmesartan medoxomil/amlodipine/hydrochlorothiazide vs Doxazosin mesilate
- Olmesartan medoxomil/amlodipine/hydrochlorothiazide vs Lisinopril